IPD

IMPEDIMED FPO [IPD]
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Healthcare · ASX Small Cap
$0.0050 +0.0%

Updated 23 Jul 2026 · Signals refresh every scan

Get alerts when IPD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track IPD — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Volume surging at 4.1x normal while price falls — heavy selling pressure
  • Sitting near support — this level has held before and could attract buyers again
  • Took a hit — down 16.7% over the last 5 days
  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Adequate cash runway (5 quarters)
  • Low P/S ratio (1.3x)
  • Strong revenue growth (+25%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (0% of range)
  • Micro-cap ($5-20M) - high risk
  • Director buying detected (4 transactions)
  • CANSLIM S: Tight float (49%)
  • CANSLIM I: Institutional ownership (21%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 86% over the past year
  • Altman Z-Score distress zone (-0.16 < 1.81, low-confidence approx)
  • Penny stock risk ($0.005)
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 7d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Deeply negative margins (-171%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-3.81%/day)
Ask Scout AI about IPD
"What's driving IPD today?" "How does IPD compare to peers?" "Key risks for IPD?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification of cessation of securities - IPD
NONE Change of Director's Interest Notice - Mr Andrew Grant
NONE Change of Director's Interest Notice - Ms Emmanuel-Donnelly
Announcement tone +3pts

Recent ASX Announcements

2026-07-20 Notification of cessation of securities - IPD
2026-07-03 Change of Director's Interest Notice - Mr Andrew Grant
2026-07-03 Change of Director's Interest Notice - Ms Emmanuel-Donnelly
2026-07-03 Change of Director's Interest Notice - Ms Janelle Delaney
2026-07-03 Change of Director's Interest Notice - Ms Fiona Bones

Key Metrics

$18.3M
Market Cap
6.1M
Avg Volume
4.1x
Vol Ratio
$0.01 — $0.06
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-117.9%
ROE
-171.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 49%
LLeader vs LaggardlaggardRS: -40
IInstitutional SponsorshippassInst: 21%
MMarket DirectionneutralNeutral

Sector: Healthcare

102 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
PIQ +23.3%SLD -18.1%ADR -17.9%IDT -17.1%VBS -14.3%
Compare:IPD vs PIQIPD vs SLDIPD vs ADR
Scout Pro — Deeper Analysis for IPD
Try Pro free for 30 days
Share this analysis

Track IPD and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required